InvestorsHub Logo
Followers 64
Posts 6681
Boards Moderated 2
Alias Born 02/07/2013

Re: Ned Serious post# 1851

Monday, 03/10/2014 8:45:07 AM

Monday, March 10, 2014 8:45:07 AM

Post# of 6939
ELTP - Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally

NORTHVALE, N.J., March 10, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (ELTP) today announced the expansion of intellectual property protection surrounding the Company's abuse deterrent technology with the issuance of Canadian Patent Number 2,521,655 titled "Abuse-Resistant Oral Dosage Forms and Method of Use Thereof". This patent issuance expands the scope and reach of Elite's patent estate internationally. Elite has additional patents pending in the U.S., Canada and Europe.

Ref. http://finance.yahoo.com/news/elite-pharmaceuticals-expands-abuse-deterrent-114634443.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.